[ad_1]
SHANGHAI (Reuters) – The Chinese health regulator has asked all medical institutions to cooperate with the authorities and not to use the drug against the blood and heart containing valsartan that would pose cancer risks.
Pharmaceutical, said earlier this month that he was recalling the drug valsartan sold in the United States after the European Medicines Agency found that it was tainted with an impurity related to cancer.
In a notice posted on his website, National Health and The Family Planning Commission stated that none of the recalled medications should be used for the diagnosis and treatment of diseases.
The warning came after a Jilin-based vaccine manufacturer falsified data and sold vaccines that were ineffective for children, the latest to date. a series of scandals that have plagued the Chinese pharmaceutical industry
Earlier this month, the Chinese drug regulator has accused Changsheng Bio-technology of making a police officers in Changchun City, northeast from China, said Sunday (July 29) that they had asked prosecutors to approve the arrest of 18 people, including the president of the company, Gao Junfang
[ad_2]
Source link
